KARA SWANSON: Open Payments
NPI 1770222838 · WAPAKONETA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 25 payments from 11 companies in 2025. Trend: 2023 $15 · 2024 $308 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Lilly USA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $32 |
| Abbott Laboratories | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
Products named: FARXIGA, MOUNJARO, VRAYLAR, NURTEC ODT, XIFAXAN, FREESTYLE LIBRE 3, QULIPTA, CAPLYTA.
Industry payments across OH — which companies pay providers there.
